Navigation Links
Researchers seek children for a study of antibiotics for a urinary tract disorder
Date:6/20/2008

Researchers conducting a study to learn if children with a urinary tract disorder known as vesicoureteral reflux (VUR) should be treated with an antibiotic for an extended period of time are seeking to enroll more participants. The study, known as the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the National Institutes of Health (NIH).

VUR is the abnormal flow of urine from the bladder back up into the tubes that run to the kidneys. These tubes are called ureters. Normally, urine flows down the ureters to the bladder. VUR is the most common functional abnormality of the urinary tract in children. It is found in 30 percent to 50 percent of children with urinary tract infections (UTIs) and is thought to increase the risk of kidney damage when children have recurring UTIs. At least 30 percent of children who have at least one UTI will have a recurrence.

Scar tissue in the kidney, called renal scarring, occurs between 5 percent and 40 percent of the time when a child has a UTI. Scarring may build up with each infection and can lead to progressive kidney failure and the need for renal-replacement therapy, such as dialysis.

About 50 years ago physicians began to prescribe an ongoing regimen of daily antibiotics for children with VUR, based on the belief that treatment would prevent infections and reduce scarring and kidney failure. Unfortunately, the number of children developing kidney failure from VUR has not changed in that time, leading physicians to question the value of the practice and adding to concerns about increasing antibiotic resistance in the general population.

"The RIVUR study has the potential to help us understand how to provide the best care for tens of thousands of children diagnosed every year with this condition," said Marva Moxey-Mims, M.D., director of NIDDK's pediatric nephrology program in the Division of Kidney, Urologic, and Hematologic Diseases. "In addition to finding out if antibiotics reduce the risk of UTIs, we also need to understand the progression of renal scarring and the development of resistance to antibiotics in these children."

The researchers seek to enroll 600 participants. So far, 125 infants and children have joined the study. Participants must be between the ages of 2 months and 6 years and have had their first UTI within the six weeks before their first study visit. With the approval of 20 institutional review boards and an external data safety monitoring board charged with overseeing the safety of children in the trial, each participant receives a daily dose of an antibiotic or a placebo for up to two years. Children who develop recurring fever or other symptoms of infection or scar tissue buildup in the kidney will be switched from the study to routine antibiotic care and referred to a urologist, depending on the number of infections and degree of renal scarring.


'/>"/>

Contact: Arthur Stone
niddkmedia@mail.nih.gov
301-496-3583
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Source:Eurekalert

Related medicine news :

1. Researchers confirm benzene-like electron delocalization of important molecule
2. Penn researchers find key developmental pathway activates lung stem cells
3. MIT researchers see alternative to common colorectal cancer drug
4. $10 million gift will retain and recruit world-class researchers to University at Buffalo
5. Researchers ID Traits of Aggressive Prostate Cancer
6. Carnegie Mellon researchers improve assessments of aortic aneurysms
7. Chemical engineering researchers identify biofilms that cause infections
8. MU researchers enhancing motion-capture technology to benefit older adults
9. Researchers Update Risk-of-Death Charts
10. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
11. Rutgers researchers show how the brain can protect against cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 10, 2016 , ... The Journal of Pain ... “level the playing field .” , As corresponding author Dr John F. Peppin says ... categorize and diagnose our chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer ...
(Date:2/9/2016)... Palm City, Florida (PRWEB) , ... February 09, ... ... providers of cold therapy products, announced today the introduction of the newly designed, ... for maximum comfort and better cold therapy coverage for the injured arm and ...
(Date:2/9/2016)... St. Petersburg, FL (PRWEB) , ... February 09, 2016 , ... Shark Finds ... of a new DRTV campaign with GRIP-DRY. , GRIP-DRY is a newly patented product that ... carts. Golfers who play in the wet and early morning dew or right after a ...
(Date:2/8/2016)... ... February 08, 2016 , ... Coast Dental has a new way ... Dental Health Month and family dentist Yvonne Dorrian, DMD, is hosting a free seminar ... , located next to Target at 1207 North Peachtree Parkway in Peachtree City. Dr. ...
(Date:2/8/2016)... ... 2016 , ... If you are feeling that your clothes are a tad ... to the Center for Disease Control and Prevention (CDC), 34.9% of U.S. adult women ... of cancer, some of the leading causes of preventable death. February is heart ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... , Feb. 9, 2016   AllCare Plus Pharmacy ... Commission,s Gold Seal of Approval ® for ... its performance standards. The Gold Seal of Approval ® ... organization,s commitment to providing safe and effective care.  ... Plus Pharmacy underwent a rigorous on-site survey in January ...
(Date:2/9/2016)... Hearing protection devices refer to the barriers ... the inner ear. Hearing protection devices include earplugs, uniform ... recommended for users exposed to noise levels of over ... that are inserted in the ear canal to protect ... more natural sound perception with the help of acoustic ...
(Date:2/9/2016)... The new report "Global Blood Monitoring & Cardiac Monitoring Devices Market ... group reveals that global market for blood monitoring & cardiac monitoring ... to grow to US$ 24,830.1 million by 2019 at a CAGR ... , Europe , Asia-Pacific ... and Africa . The three major factors ...
Breaking Medicine Technology: